Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
The Science of the Total Environment|August 29, 2019
Multidecadal environmental pollution in a mega-industrial area in central Chile registered by tree ringsAriel A Muñoz, Karin Klock-Barría, Paul R Sheppard, et al.
Archivos De Cardiologia De Mexico|February 9, 2023
Relationship of the T-wave Tpeak-Tend interval with conduction system disorders in arterial hypertensionJosé C Candia, Osmar A Centurión, José F Alderete, et al.
Journal of Fungi (Basel, Switzerland)|September 23, 2025
Evolutionary History and Distribution Analysis of Rhamnosyltransferases in the Fungal KingdomJoaquín O Chávez-Santiago, Luz A López-Ramírez, Luis A Pérez-García, et al.
JCO Global Oncology|April 18, 2025
Decentralized Point-of-Care Manufacturing of CD19 Chimeric Antigen Receptor T Cells in MexicoRosario Salazar-Riojas, Dalila M Alvarado-Navarro, Yair O Chávez-Estrada, et al.
Journal of Endocrinological Investigation|February 5, 2020
R230C but not - 565C/T variant of the ABCA1 gene is associated with type 2 diabetes in Mexicans through an effect on lowering HDL-cholesterol levelsA Ochoa-Guzmán, H Moreno-Macías, D Guillén-Quintero, et al.
Ambio|August 22, 2018
Human-environmental drivers and impacts of the globally extreme 2017 Chilean firesDavid M J S Bowman, Andrés Moreira-Muñoz, Crystal A Kolden, et al.
Reumatologia Clinica|June 12, 2025
Association of electrocardiographic altered P wave dispersion and vascular endothelial growth factor in rheumatoid arthritisOsmar Antonio Centurión, Paloma de Abreu, Gabriela Avila-Pedretti, et al.
International Journal of Cancer|October 16, 2025
HEBERSaVax immunotherapy combined with first-line chemotherapy in advanced ovarian cancer: Phase II CENTAURO-4 trial resultsFrancisco Hernández-Bernal, Katty-Hind Selman-Housein Bernal, Monica Bequet-Romero, et al.
Vaccine|August 16, 2024
Efficacy and safety of Abdala COVID-19 subunit vaccine in children and adolescents: An open-label, single-arm, phase 2 trial (MEÑIQUE)Francisco Hernández-Bernal, Enrique Noa-Romero, Joel Quintana-Guerra, et al.
Eclinicalmedicine|August 31, 2023
Immunogenicity and safety assessment of a SARS-CoV-2 recombinant spike RBD protein vaccine (Abdala) in paediatric ages 3-18 years old: a double-blinded, multicentre, randomised, phase 1/2 clinical trial (ISMAELILLO study)Zurina Cinza-Estévez, Sonia Resik-Aguirre, Nelvis L Figueroa-Baile, et al.
Pageof 4